The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Infective Ophthalmic Market Research Report 2025
Synopsis
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
The global Anti-Infective Ophthalmic market was valued at US$ 1468.1 million in 2023 and is anticipated to reach US$ 1849.8 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Ophthalmic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Ophthalmic.
Report Scope
The Anti-Infective Ophthalmic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Infective Ophthalmic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Infective Ophthalmic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group
Segment by Type
Eyedrops
Gels
Ointments
Other
Segment by Application
Hospital
Retail Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Infective Ophthalmic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Infective Ophthalmic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
The global Anti-Infective Ophthalmic market was valued at US$ 1468.1 million in 2023 and is anticipated to reach US$ 1849.8 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Ophthalmic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Ophthalmic.
Report Scope
The Anti-Infective Ophthalmic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Infective Ophthalmic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Infective Ophthalmic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group
Segment by Type
Eyedrops
Gels
Ointments
Other
Segment by Application
Hospital
Retail Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Infective Ophthalmic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Infective Ophthalmic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-Infective Ophthalmic Market Overview
1.1 Product Overview and Scope of Anti-Infective Ophthalmic
1.2 Anti-Infective Ophthalmic Segment by Type
1.2.1 Global Anti-Infective Ophthalmic Market Value Comparison by Type (2024-2030)
1.2.2 Eyedrops
1.2.3 Gels
1.2.4 Ointments
1.2.5 Other
1.3 Anti-Infective Ophthalmic Segment by Application
1.3.1 Global Anti-Infective Ophthalmic Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Anti-Infective Ophthalmic Market Size Estimates and Forecasts
1.4.1 Global Anti-Infective Ophthalmic Revenue 2019-2030
1.4.2 Global Anti-Infective Ophthalmic Sales 2019-2030
1.4.3 Global Anti-Infective Ophthalmic Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Infective Ophthalmic Market Competition by Manufacturers
2.1 Global Anti-Infective Ophthalmic Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Infective Ophthalmic Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Infective Ophthalmic Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Infective Ophthalmic Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Infective Ophthalmic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Infective Ophthalmic, Product Type & Application
2.7 Anti-Infective Ophthalmic Market Competitive Situation and Trends
2.7.1 Anti-Infective Ophthalmic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Infective Ophthalmic Players Market Share by Revenue
2.7.3 Global Anti-Infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Infective Ophthalmic Retrospective Market Scenario by Region
3.1 Global Anti-Infective Ophthalmic Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Infective Ophthalmic Global Anti-Infective Ophthalmic Sales by Region: 2019-2030
3.2.1 Global Anti-Infective Ophthalmic Sales by Region: 2019-2024
3.2.2 Global Anti-Infective Ophthalmic Sales by Region: 2025-2030
3.3 Global Anti-Infective Ophthalmic Global Anti-Infective Ophthalmic Revenue by Region: 2019-2030
3.3.1 Global Anti-Infective Ophthalmic Revenue by Region: 2019-2024
3.3.2 Global Anti-Infective Ophthalmic Revenue by Region: 2025-2030
3.4 North America Anti-Infective Ophthalmic Market Facts & Figures by Country
3.4.1 North America Anti-Infective Ophthalmic Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Infective Ophthalmic Sales by Country (2019-2030)
3.4.3 North America Anti-Infective Ophthalmic Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Infective Ophthalmic Market Facts & Figures by Country
3.5.1 Europe Anti-Infective Ophthalmic Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Infective Ophthalmic Sales by Country (2019-2030)
3.5.3 Europe Anti-Infective Ophthalmic Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Infective Ophthalmic Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Infective Ophthalmic Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Infective Ophthalmic Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Infective Ophthalmic Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-Infective Ophthalmic Market Facts & Figures by Country
3.7.1 Latin America Anti-Infective Ophthalmic Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Infective Ophthalmic Sales by Country (2019-2030)
3.7.3 Latin America Anti-Infective Ophthalmic Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Infective Ophthalmic Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Infective Ophthalmic Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Infective Ophthalmic Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Infective Ophthalmic Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Infective Ophthalmic Sales by Type (2019-2030)
4.1.1 Global Anti-Infective Ophthalmic Sales by Type (2019-2024)
4.1.2 Global Anti-Infective Ophthalmic Sales by Type (2025-2030)
4.1.3 Global Anti-Infective Ophthalmic Sales Market Share by Type (2019-2030)
4.2 Global Anti-Infective Ophthalmic Revenue by Type (2019-2030)
4.2.1 Global Anti-Infective Ophthalmic Revenue by Type (2019-2024)
4.2.2 Global Anti-Infective Ophthalmic Revenue by Type (2025-2030)
4.2.3 Global Anti-Infective Ophthalmic Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Infective Ophthalmic Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Infective Ophthalmic Sales by Application (2019-2030)
5.1.1 Global Anti-Infective Ophthalmic Sales by Application (2019-2024)
5.1.2 Global Anti-Infective Ophthalmic Sales by Application (2025-2030)
5.1.3 Global Anti-Infective Ophthalmic Sales Market Share by Application (2019-2030)
5.2 Global Anti-Infective Ophthalmic Revenue by Application (2019-2030)
5.2.1 Global Anti-Infective Ophthalmic Revenue by Application (2019-2024)
5.2.2 Global Anti-Infective Ophthalmic Revenue by Application (2025-2030)
5.2.3 Global Anti-Infective Ophthalmic Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Infective Ophthalmic Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alcon
6.1.1 Alcon Corporation Information
6.1.2 Alcon Description and Business Overview
6.1.3 Alcon Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alcon Anti-Infective Ophthalmic Product Portfolio
6.1.5 Alcon Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Anti-Infective Ophthalmic Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Bausch Health
6.3.1 Bausch Health Corporation Information
6.3.2 Bausch Health Description and Business Overview
6.3.3 Bausch Health Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bausch Health Anti-Infective Ophthalmic Product Portfolio
6.3.5 Bausch Health Recent Developments/Updates
6.4 Santen Pharmaceutical
6.4.1 Santen Pharmaceutical Corporation Information
6.4.2 Santen Pharmaceutical Description and Business Overview
6.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Product Portfolio
6.4.5 Santen Pharmaceutical Recent Developments/Updates
6.5 Lupin Pharmaceuticals
6.5.1 Lupin Pharmaceuticals Corporation Information
6.5.2 Lupin Pharmaceuticals Description and Business Overview
6.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Portfolio
6.5.5 Lupin Pharmaceuticals Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Apotex Anti-Infective Ophthalmic Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Akorn
6.6.1 Akorn Corporation Information
6.6.2 Akorn Description and Business Overview
6.6.3 Akorn Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Akorn Anti-Infective Ophthalmic Product Portfolio
6.7.5 Akorn Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Johnson & Johnson Anti-Infective Ophthalmic Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Thea pharmaceuticals
6.9.1 Thea pharmaceuticals Corporation Information
6.9.2 Thea pharmaceuticals Description and Business Overview
6.9.3 Thea pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Thea pharmaceuticals Anti-Infective Ophthalmic Product Portfolio
6.9.5 Thea pharmaceuticals Recent Developments/Updates
6.10 URSAPHARM
6.10.1 URSAPHARM Corporation Information
6.10.2 URSAPHARM Description and Business Overview
6.10.3 URSAPHARM Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.10.4 URSAPHARM Anti-Infective Ophthalmic Product Portfolio
6.10.5 URSAPHARM Recent Developments/Updates
6.11 SIMILASAN
6.11.1 SIMILASAN Corporation Information
6.11.2 SIMILASAN Anti-Infective Ophthalmic Description and Business Overview
6.11.3 SIMILASAN Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.11.4 SIMILASAN Anti-Infective Ophthalmic Product Portfolio
6.11.5 SIMILASAN Recent Developments/Updates
6.12 Jianfeng Group
6.12.1 Jianfeng Group Corporation Information
6.12.2 Jianfeng Group Anti-Infective Ophthalmic Description and Business Overview
6.12.3 Jianfeng Group Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jianfeng Group Anti-Infective Ophthalmic Product Portfolio
6.12.5 Jianfeng Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Infective Ophthalmic Industry Chain Analysis
7.2 Anti-Infective Ophthalmic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Infective Ophthalmic Production Mode & Process
7.4 Anti-Infective Ophthalmic Sales and Marketing
7.4.1 Anti-Infective Ophthalmic Sales Channels
7.4.2 Anti-Infective Ophthalmic Distributors
7.5 Anti-Infective Ophthalmic Customers
8 Anti-Infective Ophthalmic Market Dynamics
8.1 Anti-Infective Ophthalmic Industry Trends
8.2 Anti-Infective Ophthalmic Market Drivers
8.3 Anti-Infective Ophthalmic Market Challenges
8.4 Anti-Infective Ophthalmic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-Infective Ophthalmic Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-Infective Ophthalmic Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-Infective Ophthalmic Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-Infective Ophthalmic Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-Infective Ophthalmic Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-Infective Ophthalmic Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-Infective Ophthalmic Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-Infective Ophthalmic Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-Infective Ophthalmic, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Infective Ophthalmic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Infective Ophthalmic, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Infective Ophthalmic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Infective Ophthalmic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Ophthalmic as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Infective Ophthalmic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-Infective Ophthalmic Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-Infective Ophthalmic Sales Market Share by Region (2019-2024)
Table 19. Global Anti-Infective Ophthalmic Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-Infective Ophthalmic Sales Market Share by Region (2025-2030)
Table 21. Global Anti-Infective Ophthalmic Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-Infective Ophthalmic Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-Infective Ophthalmic Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-Infective Ophthalmic Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-Infective Ophthalmic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-Infective Ophthalmic Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-Infective Ophthalmic Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-Infective Ophthalmic Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-Infective Ophthalmic Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-Infective Ophthalmic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-Infective Ophthalmic Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-Infective Ophthalmic Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-Infective Ophthalmic Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-Infective Ophthalmic Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-Infective Ophthalmic Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-Infective Ophthalmic Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-Infective Ophthalmic Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-Infective Ophthalmic Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Infective Ophthalmic Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-Infective Ophthalmic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-Infective Ophthalmic Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-Infective Ophthalmic Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-Infective Ophthalmic Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-Infective Ophthalmic Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-Infective Ophthalmic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-Infective Ophthalmic Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-Infective Ophthalmic Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-Infective Ophthalmic Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-Infective Ophthalmic Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-Infective Ophthalmic Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-Infective Ophthalmic Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-Infective Ophthalmic Sales Market Share by Type (2019-2024)
Table 53. Global Anti-Infective Ophthalmic Sales Market Share by Type (2025-2030)
Table 54. Global Anti-Infective Ophthalmic Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-Infective Ophthalmic Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-Infective Ophthalmic Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-Infective Ophthalmic Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-Infective Ophthalmic Price (USD/Unit) by Type (2019-2024)
Table 59. Global Anti-Infective Ophthalmic Price (USD/Unit) by Type (2025-2030)
Table 60. Global Anti-Infective Ophthalmic Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-Infective Ophthalmic Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-Infective Ophthalmic Sales Market Share by Application (2019-2024)
Table 63. Global Anti-Infective Ophthalmic Sales Market Share by Application (2025-2030)
Table 64. Global Anti-Infective Ophthalmic Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-Infective Ophthalmic Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-Infective Ophthalmic Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-Infective Ophthalmic Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-Infective Ophthalmic Price (USD/Unit) by Application (2019-2024)
Table 69. Global Anti-Infective Ophthalmic Price (USD/Unit) by Application (2025-2030)
Table 70. Alcon Corporation Information
Table 71. Alcon Description and Business Overview
Table 72. Alcon Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Alcon Anti-Infective Ophthalmic Product
Table 74. Alcon Recent Developments/Updates
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. AbbVie Anti-Infective Ophthalmic Product
Table 79. AbbVie Recent Developments/Updates
Table 80. Bausch Health Corporation Information
Table 81. Bausch Health Description and Business Overview
Table 82. Bausch Health Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Bausch Health Anti-Infective Ophthalmic Product
Table 84. Bausch Health Recent Developments/Updates
Table 85. Santen Pharmaceutical Corporation Information
Table 86. Santen Pharmaceutical Description and Business Overview
Table 87. Santen Pharmaceutical Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Santen Pharmaceutical Anti-Infective Ophthalmic Product
Table 89. Santen Pharmaceutical Recent Developments/Updates
Table 90. Lupin Pharmaceuticals Corporation Information
Table 91. Lupin Pharmaceuticals Description and Business Overview
Table 92. Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Lupin Pharmaceuticals Anti-Infective Ophthalmic Product
Table 94. Lupin Pharmaceuticals Recent Developments/Updates
Table 95. Apotex Corporation Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Apotex Anti-Infective Ophthalmic Product
Table 99. Apotex Recent Developments/Updates
Table 100. Akorn Corporation Information
Table 101. Akorn Description and Business Overview
Table 102. Akorn Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Akorn Anti-Infective Ophthalmic Product
Table 104. Akorn Recent Developments/Updates
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Johnson & Johnson Anti-Infective Ophthalmic Product
Table 109. Johnson & Johnson Recent Developments/Updates
Table 110. Thea pharmaceuticals Corporation Information
Table 111. Thea pharmaceuticals Description and Business Overview
Table 112. Thea pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Thea pharmaceuticals Anti-Infective Ophthalmic Product
Table 114. Thea pharmaceuticals Recent Developments/Updates
Table 115. URSAPHARM Corporation Information
Table 116. URSAPHARM Description and Business Overview
Table 117. URSAPHARM Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. URSAPHARM Anti-Infective Ophthalmic Product
Table 119. URSAPHARM Recent Developments/Updates
Table 120. SIMILASAN Corporation Information
Table 121. SIMILASAN Description and Business Overview
Table 122. SIMILASAN Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. SIMILASAN Anti-Infective Ophthalmic Product
Table 124. SIMILASAN Recent Developments/Updates
Table 125. Jianfeng Group Corporation Information
Table 126. Jianfeng Group Description and Business Overview
Table 127. Jianfeng Group Anti-Infective Ophthalmic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Jianfeng Group Anti-Infective Ophthalmic Product
Table 129. Jianfeng Group Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Anti-Infective Ophthalmic Distributors List
Table 133. Anti-Infective Ophthalmic Customers List
Table 134. Anti-Infective Ophthalmic Market Trends
Table 135. Anti-Infective Ophthalmic Market Drivers
Table 136. Anti-Infective Ophthalmic Market Challenges
Table 137. Anti-Infective Ophthalmic Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Infective Ophthalmic
Figure 2. Global Anti-Infective Ophthalmic Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-Infective Ophthalmic Market Share by Type in 2023 & 2030
Figure 4. Eyedrops Product Picture
Figure 5. Gels Product Picture
Figure 6. Ointments Product Picture
Figure 7. Other Product Picture
Figure 8. Global Anti-Infective Ophthalmic Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Anti-Infective Ophthalmic Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Retail Pharmacy
Figure 12. Others
Figure 13. Global Anti-Infective Ophthalmic Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Anti-Infective Ophthalmic Market Size (2019-2030) & (US$ Million)
Figure 15. Global Anti-Infective Ophthalmic Sales (2019-2030) & (K Units)
Figure 16. Global Anti-Infective Ophthalmic Average Price (USD/Unit) & (2019-2030)
Figure 17. Anti-Infective Ophthalmic Report Years Considered
Figure 18. Anti-Infective Ophthalmic Sales Share by Manufacturers in 2023
Figure 19. Global Anti-Infective Ophthalmic Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Anti-Infective Ophthalmic Players: Market Share by Revenue in 2023
Figure 21. Anti-Infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Anti-Infective Ophthalmic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Anti-Infective Ophthalmic Sales Market Share by Country (2019-2030)
Figure 24. North America Anti-Infective Ophthalmic Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Anti-Infective Ophthalmic Sales Market Share by Country (2019-2030)
Figure 28. Europe Anti-Infective Ophthalmic Revenue Market Share by Country (2019-2030)
Figure 29. Germany Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Anti-Infective Ophthalmic Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Anti-Infective Ophthalmic Revenue Market Share by Region (2019-2030)
Figure 36. China Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Anti-Infective Ophthalmic Sales Market Share by Country (2019-2030)
Figure 46. Latin America Anti-Infective Ophthalmic Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Anti-Infective Ophthalmic Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Anti-Infective Ophthalmic Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Anti-Infective Ophthalmic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Anti-Infective Ophthalmic by Type (2019-2030)
Figure 56. Global Revenue Market Share of Anti-Infective Ophthalmic by Type (2019-2030)
Figure 57. Global Anti-Infective Ophthalmic Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Anti-Infective Ophthalmic by Application (2019-2030)
Figure 59. Global Revenue Market Share of Anti-Infective Ophthalmic by Application (2019-2030)
Figure 60. Global Anti-Infective Ophthalmic Price (USD/Unit) by Application (2019-2030)
Figure 61. Anti-Infective Ophthalmic Value Chain
Figure 62. Anti-Infective Ophthalmic Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
